Literature DB >> 15597839

The value of human papillomavirus detection in primary cervical cancer screening.

M F D Baay1, J Weyler, J B Vermorken.   

Abstract

Human papillomavirus (HPV) is present in the vast majority of high-grade gynecological abnormalities (high-grade squamous intraepithelial lesions and worse) and, therefore, HPV detection has a very high negative predictive value. Nevertheless, introduction of HPV detection into primary screening would result in large numbers of false positives: HPV positive women with normal cytology. The prevalence of HPV in women with cytologically normal smears is age-dependent as has been shown extensively. We hypothesize that women at the age of 50, who are HPV negative and have a cytologically normal smear might be encouraged to refrain from further screening. The data available from the literature on HPV prevalence in elderly women is presented. Data of cohort studies of elderly women with and without HPV infection as well as health-economical analyses to investigate the cost-effectiveness of the proposed hypothesis are still lacking.

Entities:  

Mesh:

Year:  2004        PMID: 15597839

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  2 in total

1.  PAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study.

Authors:  Hung-Cheng Lai; Yu-Che Ou; Tze-Chien Chen; Huei-Jean Huang; Ya-Min Cheng; Chi-Hau Chen; Tang-Yuan Chu; Shih-Tien Hsu; Cheng-Bin Liu; Yao-Ching Hung; Kuo-Chang Wen; Mu-Hsien Yu; Kung-Liahng Wang
Journal:  Cancer Med       Date:  2014-05-03       Impact factor: 4.452

2.  Combined clinical and genetic testing algorithm for cervical cancer diagnosis.

Authors:  Yu-Ligh Liou; Tao-Lan Zhang; Tian Yan; Ching-Tung Yeh; Ya-Nan Kang; Lanqin Cao; Nayiyuan Wu; Chi-Feng Chang; Huei-Jen Wang; Carolyn Yen; Tang-Yuan Chu; Yi Zhang; Yu Zhang; Honghao Zhou
Journal:  Clin Epigenetics       Date:  2016-06-10       Impact factor: 6.551

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.